Q32 Bio initiated with an Overweight at Wells Fargo
PremiumThe FlyQ32 Bio initiated with an Overweight at Wells Fargo
2M ago
Q32 Bio reports Q2 EPS ($1.42), consensus ($1.04)
Premium
The Fly
Q32 Bio reports Q2 EPS ($1.42), consensus ($1.04)
3M ago
Q32 Bio Advances in Atopic Dermatitis Treatment Trial
Premium
Company Announcements
Q32 Bio Advances in Atopic Dermatitis Treatment Trial
4M ago
Q32 Bio initiated with a Buy at Guggenheim
PremiumThe FlyQ32 Bio initiated with a Buy at Guggenheim
5M ago
Disney and HP upgraded: Wall Street’s top analyst calls
Premium
The Fly
Disney and HP upgraded: Wall Street’s top analyst calls
6M ago
Q32 Bio initiated with an Outperform at Leerink
Premium
The Fly
Q32 Bio initiated with an Outperform at Leerink
6M ago
Q32 Bio initiated with an Outperform at Oppenheimer
PremiumThe FlyQ32 Bio initiated with an Outperform at Oppenheimer
7M ago
Q32 Bio names Lee Kalowski as CFO
Premium
The Fly
Q32 Bio names Lee Kalowski as CFO
7M ago
Q32 Bio  initiated with an Overweight at Piper Sandler
Premium
The Fly
Q32 Bio initiated with an Overweight at Piper Sandler
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100